![](/img/cover-not-exists.png)
Vemurafenib as first line therapy in BRAF-mutated Langerhans cell histiocytosis
Haroche, Julien, Cohen-Aubart, Fleur, Emile, Jean-François, Donadieu, Jean, Amoura, ZahirVolume:
73
Language:
english
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2014.10.045
Date:
July, 2015
File:
PDF, 64 KB
english, 2015